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Human  gut  microbiota  is  a complex  ecosystem  with  several  functions  integrated  in the  host  organism
(metabolic,  immune,  nutrients  absorption,  etc.).  Human  microbiota  is  composed  by  bacteria,  yeasts,  fungi
and,  last  but  not  least,  viruses,  whose  composition  has  not  been  completely  described.
According  to  previous  evidence  on  pathogenic  viruses,  the  human  gut harbours  plant-derived  viruses,
giant  viruses  and, only  recently,  abundant  bacteriophages.  New  metagenomic  methods  have  allowed
to  reconstitute  entire  viral  genomes  from  the  genetic  material  spread  in the  human  gut,  opening  newiant virus
ut microbiota
ut virome
icroviridae
perspectives  on  the  understanding  of  the  gut  virome  composition,  the importance  of  gut  microbiome,
and  potential  clinical  applications.
This  review  reports  the latest  evidence  on  human  gut “virome”  composition  and  its  function,  possible
future  therapeutic  applications  in  human  health  in the  context  of  the  gut  microbiota,  and  attempts  to
clarify  the  role  of  the  gut “virome”  in  the  larger  microbial  ecosystem.
 Gast© 2015  Editrice
. Introduction
Before the surge of interest into neglected components of the
gut microbiota” (including fungi and viruses), studies on the “gut
acterial microﬂora” and its widespread and well known bacte-
ial species have collected evidence on the microbiota’s role in
etabolic, gastrointestinal, immune diseases and, lately, in cancer
evelopment [1].
The Western lifestyle is associated with serious metabolic
equelae (diabetes, obesity, metabolic syndrome, increased cardio-
ascular risk, etc.) [2]; this has driven clinical and basic researchers’
ttention to the possible modulation of gut microﬂora through diet,
ntibiotics, and pre-/probiotics with encouraging results, however
waiting wider population-based studies [2].
Thus, the microbiologic environment has attracted attention
nd resources from the clinical and economic sectors of our soci-
ty to achieve a better understanding of the microbiota ecosystem.
hese efforts have led to the discovery of other components of gut
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microbiota such as yeasts, fungi, archaea, and last but not least,
viruses [1].
This last subset of ﬁndings has been mostly unexpected because
of the common representation of the gut virome as a source of
pathogens. Enteroviruses, Norwalk, Rotaviruses are well known in
daily clinical practice and are known to be responsible for common
infectious gastroenteritis [3].
However, because gut viruses not amenable to culture with
common microbiological techniques, the development of non-
culture based metagenomic methods have allowed to reconstitute
viral particles from single genetic sequences from almost every
environment. This has moved our idea of gut viruses from a mere
source of pathogens to a physiological component of the healthy
human microbiota [3].
Based on the new ﬁndings obtained through metagenomic
methods, this review will focus on the composition of the human
gut virome, its role in the gut microbiota ecosystem, and possible
future clinical applications.
2. Human gut microbiota compositionAfter birth the human intestine is progressively colonized by
several microbial strains that ﬂuctuate and change during our
lifespan according to anatomical, dietary and nutritional status
 rights reserved.
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hanges (e.g. obese, anorexic, lean nutritional status), environmen-
al (e.g. climate, familial composition, life-style, working place,
tc.), pathological (gastro-intestinal and systemic infections), and
harmacological factors (e.g. use of antibiotics, prokinetics, laxa-
ives, probiotics) [4].
The main components of gut microbiota are bacteria, fungi,
easts, archaea and viruses [4]. While the Human Gut Microbiome
roject has shed new light on the entire human intestinal bacte-
ial composition, the last three decades of microbiological/clinical
esearch have helped to understand how food, pre-/probiotics,
ntibiotics can modulate the intestinal bacteria quali-/quantitative
attern resulting in different microbial-host functions [2–5].
Speciﬁcally starting from the observations of an obese/lean gut
icrobiota associated with overweight or lean status it became
lear how microbiota manipulation by diet was possible and how
icrobiota could be responsible not only for overweight but also for
he chronic inﬂammatory state typical of the metabolic syndrome
MetS) [6]. However diet and the gut microbiota’s role in obe-
ity pathogenesis is not simply causative as was initially expected.
n fact, a recent observation by Ridaura et al. has showed how
o-housing mice with an obese twin’s microbiota with mice con-
aining the lean co-twin’s microbiota prevented the development of
ncreased body mass and obesity-associated metabolic phenotypes
greater polysaccharides metabolism and proteins degradation) in
bese cage mates. More interestingly, an obesogenic diet (high in
aturated fats and low in fruits and vegetables) counteracted the
rotective effect of the lean gut microbiota observed during lean
nd obese mice co-housing [7]. The role of diet in gut microbiota
odulation is strengthened by the recent metagenome-wide asso-
iation study by Qin et al. in type 2 diabetic patients, with a mainly
iet-associated insulin resistance status; the Authors showed that
hese patients have a peculiar decrease in some butyrate-producing
acteria, an increase in various opportunistic pathogens and an
nrichment of other microbial functions conferring sulphate reduc-
ion and oxidative stress resistance [8].
Starting from these observations, the possible functions of gut
icrobiota were quickly related to other organs/apparata. The pre-
ious association between spontaneous bacterial peritonitis and
mall bowel bacterial overgrowth in liver cirrhosis [9] has led to
he understanding of the microbial molecular patterns triggering
nﬂammation and ﬁbrosis in liver diseases such as non-alcoholic
iver disease (NAFLD) and its complications, i.e., non-alcoholic
teatohepatitis (NASH), liver cirrhosis and hepatocellular carci-
oma (HCC) [10]. Moreover, as in a vicious cycle, the role of
icrobial pathogen molecular patterns (PAMPs, e.g. gram-negative
olysaccharide, LPS) in NAFLD pathophysiology has been linked to
hose of MetS, which is frequently concomitant [10].
More recently intestinal bacteria have been implicated in the
athophysiology of psychiatric diseases such autism [11]. In fact,
ut bacteria seem to interact with the central nervous system (CNS)
ia the enteric nervous system through the endocannabinoid sys-
em. Thus gut microbiota can affect the neuro-psychiatric state of
he host and, conversely, the CNS is able to affect its composition
hrough food intake regulation [11,12].
Bacteria reach more than 1 kg of weight and account for more
han 1100 species; Bacteroidetes and Firmicutes are the predomi-
ant phyla in adults, followed by Actinobacteri and Proteobacteria
13].
Indeed, the human microbiota also contains other more
eglected components such as archaea, viruses, fungi, yeasts and
ther Eukarya (such as Blastocystis and Amoebozoa) [4,13].
Little is still known about commensal fungi, archaea and proto-oa [4,13].
However, some emerging microbiological data on yeast compo-
ition and functions have clariﬁed their subsequent clinical use in
he modulation of gut microﬂora. In fact, Saccharomyces boulardiir Disease 47 (2015) 1007–1012
is currently used with signiﬁcant efﬁcacy over placebo in the treat-
ment of post-infectious and post-antibiotic diarrhoea [14].
Knowledge on the composition of the gut virome has evolved
from a niche of the gut microbiome populated by pathogens only
(e.g. Norwalk, Rotavirus, Enterovirus, etc.), responsible for gas-
troenteritis by direct damage of enterocytes or through alteration
of ion and water secretion in the colon, to an enlarged list of unde-
tectable giant viruses (derived mainly from protozoa and parasites),
and more recently to plant-derived viruses and bacteriophages,
thanks to new metagenomic methods [3,13].
3. Human gut virome composition
As mentioned above the concept of the existence of a “gut
virome” is, paradoxically, very recent [3] although the presence
of viruses as pathogenic organisms in human intestine has been
known and documented for more than a century [13].
Thus, the description of the gut virome composition can begin
with these pathogenic viruses (Table 1), whose viral particles
were discovered by microbiologists mainly because they could
be cultured [13,15]. Norwalk, Rotavirus and Enterovirus are the
well-known agents of gastroenteritis in man  [15]. The reason we
consider linking these pathogens with the gut virome is that the
infection of the gut is responsible for enterocyte and bacterial
microﬂora changes. These can affect the host not only in the acute
phase of the infection with gastrointestinal complaints such as nau-
sea, vomiting, diarrhoea and weight loss, but also in the long-term
with persistence of symptoms and the possible eliciting of func-
tional gastrointestinal disorders such as functional dyspepsia and
post-infectious irritable bowel syndrome [16] (Table 1).
A recent paper by Li et al. offers a clear and advanced example
of how metagenomics has changed the professional perspectives
of microbiologists and translational researchers in the study of gut
microbiome. Using ﬁrst national, then intercontinental catalogues
of reference genes of the human gut microbiome, in the last two
decades, researchers used sequence reads and relative gene content
to map  the proﬁle of the microbial species in biological samples.
This is the fundamental principle of metagenomics which, instead
of deep genome sequencing after sample culture, collects different
sequences from various genetic materials (e.g. from human gut)
and is able to use them to mark families, taxa and genera for both
microbiome and virome. The knowledge of gene abundance levels
can be also associated to different diseases in the attempt to setup a
speciﬁc genetic marker. Another advantage of metagenomic anal-
ysis arises from the possibility to extract genetic material directly
from faecal samples without any changes and/or contamination,
which may arise during culture [17].
Very recently, thanks to these metagenomic methods, novel
enteric eukaryotic viruses were found to be responsible for acute
diarrhoea in children’s small bowel enteropathy in developing
areas of Australia. Interestingly these new data, conﬁrmed by
quantitative real time polymerase chain reaction, have shown
that diarrhoea in children contains a higher abundance of viruses,
many of them not previously known to be pathogenic, such as
the Adenoviridae, Picornaviridae, Reoviridae families. Within the
Picornaviridae family, Enterovirus were the most represented [18].
In the past decades microbiological investigations have fur-
ther discovered viruses infecting human intestinal parasites such
as amebae (e.g. Mimiviridae, Mamaviridae, Marseilleviridae) from
cooling towers, rivers, lakes, and seawater. These viruses are
deﬁned “giant” because of their dimensions. They are DNA viruses
and their existence has been frequently doubted because they
are undetectable by small-pore ﬁltration (Table 1). Some of the
Mimiviruses have been associated with pneumonitis and diarrhoea
in humans although evidence is controversial [19].
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Table  1
Known virotypes according to culturomics and metagenomics.
Virus type Genome type Environment Associated disease
Eukaryotic virus
Rotavirus, Astrovirus, Calicivirus, Norovirus, Hepatitis E virus,
Coronavirus and Torovirus, Adenovirus (serotypes 40 and 41)
All RNA except
Adenovirus (DNA)
Human small bowel
and colon
Gastroenteritis (small bowel
epithelium and the absorptive
villi disruption, with
consequent malabsorption of
water and an electrolyte
imbalance) (all the mentioned
eukaryotic viruses)
Adenoviridae, Picornaviridae and Reoviridae (genus
enterovirus)
RNA Human intestine Unknown (all the mentioned
viruses)
Plant  derived virus
Pepper mild mottle virus (PMMV), oat blue dwarf virus,
Grapevine asteroid mosaic-associated virus, Maize chlorotic
mottle virus, Oat chlorotic stunt virus, Panicum mosaic virus,
Tobacco mosaic virus
RNA Plants and human
faeces
Pathogenic for plants
Non pathogenic for humans
(all the mentioned plant
derived viruses)
Giant  virus (>300 kb)
Mimiviridae, Mamaviridae, Marseilleviridae, Poxviridae,
Iridoviridae, Ascoviridae, Phycodnaviridae, Asfaviridae
DNA Human faecal
protists, amoebae in
lake, river and
seawater
Pneumonitis, Children
diarrhoea (Mimiviridae only)
Prophages
Myoviridae, Siphoviridae, Podoviridae, Tectiviridae,
Leviviridae, Inoviridae
dsDNA Human faeces
specimens
Unknown (all the mentioned
prophages)
Virus  (<145 kb)
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ssDNA 
sDNA: double stranded DNA; ssDNA: single stranded DNA.
More recently plant viruses such as pepper mild mottle
irus (PMMV), oat blue dwarf virus, grapevine asteroid mosaic-
ssociated virus, maize chlorotic mottle virus, oat chlorotic stunt
irus, panicum mosaic virus, and tobacco mosaic virus have been
escribed [20] (Table 1).
Their biological importance depends on their concomitant
resence in plants as pathogens and as “commensals” in human
aeces, explaining how food intake has conditioned and continues
o condition human gut virome composition and enterocyte
ife-cycle. These data also suggest that these small plant-derived
iruses can affect the intestinal bacterial quali-/quantitative
omposition and its functioning with consequences for the human
ost. There is no data on the presence of these viruses in patients
ith diarrhoea [20].
Finally yet importantly, intestinal bacteriophages have been dis-
overed as the main component of the gut virome, accounting for
bout 90% of its composition [3].
Bacteriophages were one of the ﬁrst microbiological entities
haracterized in the literature. Our knowledge about their life cycle
s quite extensive; bacteriophages can be quite literally deﬁned as
viruses of bacteria”. Bacteriophages are commonly known as bac-
erial “parasites”, who inject their genome in their host, integrating
ith its genetic material (prophage state) and inducing other phage
article synthesis with bacterial cell lysis (lytic state) [3,21].
Bacteriophages are viruses with double-stranded DNA (dsDNA)
22,23]. Single-stranded DNA (ssDNA) bacteriophages are mainly
ound among the Microviridae family and were initially considered
econdary players in the environmental viral community because
f their modest genome size [3,22,24].
Microviridae are small icosahedral viruses with circular single-
tranded DNA genomes [22] and their members are divided into
icroviruses (genus Microvirus) and gokushoviruses (subfam-
ly Gokushovirinae) [24]; more recently, a new sub-family, the
lpavirinae, was described (Table 1). These viruses have been
etrieved in bacteria belonging to two genera of the phylum Bac-
eroidetes: Prevotella and Bacteroides, with possible implications
or human microbiota metabolism [22].Seawater, human gut
bacteria
Unknown (all the mentioned
Microviridae viruses)
As described above, the study of gut virome composition has
beneﬁted from new non-culture based metagenomic methods.
Thus, starting from viral genetic sequences, it has been pos-
sible to progressively classify the gut virome composition into
families. These phage sequences had not been taxonomically clas-
siﬁed beyond the family level, therefore microbiologists could not
associate and/or correlate this composition to those of intestinal
bacterial species. Very recently, Waller et al. used metagenomic
viral sequences with a newer sampling procedure for microbial
communities characterization at the taxa (about 15 taxa) and
genera level. Moreover, these marker genes were found to be
absent from ‘non-prophage’ regions of bacterial chromosomes. The
marker genes are used to detect phage sequences in metagenomic
samples containing both prokaryotes and phage DNA. Interest-
ingly, Picovirinae and Spounavirinae genomes could be isolated
from human-associated bacteria (e.g. Staphlococcus, Streptococ-
cus, Clostridium, Mycoplasma, Listeria, Enterococcus, Bacillus). In
particular, among the seven identiﬁed viral genera associated to
bacterial genera, P22-like genus was found to be connected to
genera of the Enterobacteraceae family (Escherichia, Salmonella,
Klebsiella), or Spounavirinae with those of the Bacteroidales order.
However, over 60% of the metagenomically marked genes could
not be used to identify phage genera possibly associated with
the respective bacteria, because of the methodological bias of not
including lytic genomes [25].
4. Virome functions within the human gut microbiome
Currently there are few clear data regarding gut virome func-
tions within the gut microbiota ecosystem. However, the life cycle
of viruses provides indirect information about their possible roles.
The great part of the phages found in the human gut show a
typical “temperate” behaviour, thus justifying the hypothesis that
their composition is quite stable during the host’s life, although
the viruses are able to mutate spontaneously. In fact, several
authors have used the terms “stability” and “variability” to deﬁne
phage behaviour. It is interesting to note that these two kinds of
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haracteristics belonging to the bacteriophages in the intestine
re linked as in a “virtuous” cycle. In fact, the stability of the viral
enome is responsible for that of other microorganisms, such as
he bacteria of the gut microbiota. This is proven by the fact that
ut virome composition mimics the evolution of the infant bac-
erial microbiota, perhaps remaining stable in adult life [3,26,27],
nd by 51 hypervariable loci found in virus-like particles (VLPs)
uriﬁed from human faecal samples. These are common between
hages and bacteria, and are implicated in bacterial wall adhesion,
mmunoglobulin receptor synthesis, contributing to maintaining
iral–bacterial immune tolerance in the gut. This allows the
ersistence of bacterial and viral species in the gut, exerting their
ffects on enterocytes and, more in general, on the host [3,28,29].
On the other hand the presence of one intrinsic variability, typ-
cal of the few lytic phages found in the intestine, not triggered by
rugs or other environmental factors, including bacterial pressure,
s an interesting characteristic of these viruses, allowing the gen-
ration of new species in a short time frame and allowing them to
scape extinction [26].
Indeed, among the genes stably conserved during intesti-
al viral evolution discovered by metagenomics, there are also
hose involved in energy harvesting such as for carbohydrate
ransport and degradation [30–32]. These properties are com-
on to diet-derived viruses of plants that can modulate human
acterial microbiota/host metabolism (e.g. carbohydrate synthe-
is/degradation, protein synthesis) [15]. This ﬁnding merits some
nterpretation according to those observed in intestinal bacterial
pecies.
Cani et al. have discovered the association between lean and
bese gut bacterial microbiota and their respective metabolic
atterns [33] in man. A similar viral–metabolic association is con-
eivable also according to the evidence that twin pairs and their
others have phage and bacterial community similarities in paral-
el with the same dietetic regimen assumed over time [30,34–36].
These data on the possible role of gut virome on metabolism reg-
lation should be related to those derived from the intercontinental
tudy by Li et al. on enrichment of gene catalogues. The authors
howed how the phage intercontinental virome catalogue abun-
ance is deeply inﬂuenced by a small group of individuals sampled,
ainly genes involved in metabolism regulation and/or antibiotic
esistance. On the other hand, similarly to the “Darwin postulate”
n animal species survival, the most common genes mapped by the
argest part of sampled individuals were those responsible for DNA
eplication and repair, namely a feature of “adaptation for survival”
25]. Thus gut virome has a deep inﬂuence on our gut microbiome
nd, perhaps, human genome maintenance over the generations.
Among the genes encoded in cryptic prophages of
scherichia coli, those for resistance to antibiotics and other
tress factors have been found [37]. These ﬁndings explain the
trict interaction between viral and bacterial particles in the
ntestine, a peculiar biological relationship that overcomes, only
n this environment, the classical concept of bacteriophages as
predators” of bacteria. In fact, the transmission of genes between
irus and the infected bacteria help the host to resist oxidative
tress and antibiotic use, another proof of the “temperate” lifestyle
f the gut virome.
Very recent evidence from the literature shows how the interac-
ion of eukaryotic viruses and bacteriophages in the microbial gut
cosystem is more complicated than expected, especially consider-
ng animal models of inﬂammatory bowel disease (IBD). Kernbauer
t al. have shown how persistent infection by the murine RNA
orovirus strain CR6 is able to induce intestinal pathology in mice
ho are deﬁcient in the IBD gene Atg16l1; however, in germ-free
r antibiotic-treated animals, it is also able to re-establish the
ormal mucosal immunity and trophism, resembling the functions
f commensal bacteria [38]. In this context, these ﬁndings arer Disease 47 (2015) 1007–1012
supported by the very recent work by Norman et al. showing how
bacteriophages also play a role in the maintenance of mucosal
inﬂammation in IBD with speciﬁc ulcerative colitis (UC) and
Crohn disease (CD)-associated phage expansion. In particular,
Caudovirales and Microviridae are more abundant in IBD in com-
parison with household members and controls but with a different
Caudovirales genetic sequence distribution. These different bac-
teriophage increases, in UC and CD, were associated with a lower
bacterial diversity, in general, and, more interestingly, with a
peculiar disease-speciﬁc bacterial strain abundance. This implies a
function of bacteriophages in the maintenance of mucosal inﬂam-
mation in IBD, with a possible function as viral and bacterial antigen
“generators” (namely PAMPs production) via their lytic state [39].
Altogether, these data show how viruses could be the tar-
get or even a means to face the pressing issue of antibiotic
resistance, immune modulation in immune-related diseases, and
human metabolism regulation.
5. Human virome therapeutic implications and future
directions
The brief description of the evidence arising from metagenomic
studies on gut virome is the basis of the discussion on the possible
future therapeutic use of gut virome modulation in human health.
Considering the discovery of plant-derived virus [20] one can
postulate that diet could favourably modulate gut virome com-
position and, in turn, the resident bacterial microﬂora. Moreover,
although the genetic engineering of new probiotic strains is rapidly
growing, and may  produce patient-speciﬁc gut microﬂora modula-
tion in a few years’ time, the engineered modulation of gut virome
through more “natural” pathways seems to be safer. In fact, not only
diet, but also the use of probiotics and prebiotics can potentially
affect gut virome composition. Finally, if metagenomic knowl-
edge continues to progress, the engineering of viral genomes, and
of bacteriophages in particular, could represent a patient-speciﬁc
treatment “ﬁnal destination”. In particular, the ability to create
viruses able to affect intestinal bacteria and impact on human
metabolism seems to be one of the most important targets; a more
direct application such as the prevention of viral gastroenteritis
through a competitive competition for the gut microbiome ecosys-
tem harbouring is also a possible therapeutic target [3].
Another potential use for bacteriophages is the regulation of
immune response. In CD patients the evidence of a critical preva-
lence of sDNA Caudovirales and non-tailed ssDNA Microviridae,
which alone and combined with related bacterial species condition
the inﬂammatory response in IBD, is the basis for future phage-
speciﬁc treatments. In fact, blocking bacteriophage infection of
their bacterial hosts could alter the natural history of IBD. More-
over, since phage genes are more stable than those of bacteria, their
catalogues can be used to set up an IBD marker (e.g. disease-speciﬁc
Caudovirales could differentiate CD from UC when the clinical phe-
notype is indistinguishable) [39].
As mentioned above, an emerging problem in human health
is the alarming prevalence of antibiotic-resistant strains of
pathogenic bacteria, due to the horizontal and vertical transmis-
sion of resistance (e.g. multi-resistant Staphylococcus aureus,  and
more recently New Delhi metallo-beta-lactamase enterobacteri-
aceae) [37]. Indeed although huge efforts have been made by
pharmaceutical industries, only a few novel antibiotics against
these multi-resistant agents have been produced over the past
decades [40].
In addition, the rationale for the use of bacteriophages against
antibiotic resistance is the fact that these agents can actively down-
regulate the proliferation of pathogenic multi-resistant bacteria
and be used, after genetic manipulation, for the introduction of
genes against pathogens [41].
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Fig. 1. Potential future therapeutic applications of bacteriophages in humans. Panel A: The “classic” lytic phage use as an antimicrobial, as a mono-phagic administration,
has  been stopped due to rapid bacterial resistance development from clonal selection and alterations in phage preparation. Panel B: Multiple phage administration can
quickly overcome pathogenic bacteria resistance, in a synergistic action with antibiotics. Panel C: Phages could be used for gut microbiota modulation, in general, and for
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egradation, genetic modulation with the gut microbiome, and host beneﬁcial effec
Nonetheless, this therapeutic approach has been considered
nreliable for decades although phages were discovered one cen-
ury ago. A clearer metagenomic knowledge of the gut virome
enome, together with more reﬁned and speciﬁc genetic manip-
lation engineering techniques have made this option deﬁnitively
easible.
Speciﬁcally, bacteriophage use is reliable because they have low
roduction costs, are easy to manipulate and have good target-host
peciﬁcity with bacterial resistance that develops more slowly than
or antibiotics [30,40]. Furthermore, the potential development of
acterial resistance to bacteriophages alone could be easily con-
rolled by the combined use of antibiotics and bacteriophages in
heir lytic state (Fig. 1).
In a wider future perspective, the use of phages for gut micro-
iota modulation could have several therapeutic applications:
ytic bacteriophages could modulate gut bacterial composition
aintaining a “healthy” quali- and quantitative composition;
acteriophages alone or in combination with antibiotics could over-
ome bacterial antibiotic resistance; pro- and/or prebiotics could be
sed to modulate intestinal phages with yet unknown implications
or the host physiology (Fig. 1).
The use of viruses, and of bacteriophages in particular, for
ut microﬂora and microbiota modulation also raises the need to
ddress safety concerns. Many safety issues, however, can be set
side due to the large body of evidence that no known detrimental
ffect in humans exposed to and living with millions of bacterio-
hages has been described [3].
One of the limitations of this review arises from source liter-
ture data: to date there are only association studies with human
ealth and diseases of gut microbiota, in general, and gut virome, in
articular. Thus, it is not possible to speculate or deﬁne a causativee or in combination with pre-/probiotics, as “vectors” for nutrient biosynthesis and
. in obese, dysmetabolic patients) in a more “stable” microbiota environment.
association, with solid pathophysiologic inferences, between gut
microbiota and virome alterations and human diseases.
Only larger studies on gut virome composition with metage-
nomic methods may  further enrich our knowledge on the
physiological importance of phages in the gut microbiome; only
robust animal and human interventional studies on phage modula-
tion can be provide a solid basis for future therapeutic implications.
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